Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance

Bibliographic Details
Main Author: Turner, J. Rick (-)
Other Authors: Durham, Todd A.
Format: eBook
Language:Inglés
Published: Hoboken, N.J. : John Wiley & Sons c2009.
Subjects:
Online Access:https://recursos.uloyola.es/login?url=https://accedys.uloyola.es:8443/accedix0/sitios/ebook.php?id=178306
See on Universidad Loyola - Universidad Loyola Granada:https://colectivo.uloyola.es/Record/ELB178306
Request an interlibrarian loan: Email
Table of Contents:
  • The importance of cardiac safety assessments
  • The biological basis of adverse drug reactions
  • Cardiac structure and function
  • Cardiac pathophysiology and disease
  • Drug discovery and drug design
  • Nonclinical development
  • The thorough QT/QTc trial
  • General safety assessments
  • Therapeutic use trials and meta-analyses
  • Assessment methodologies in nonexperimental postmarketing surveillance
  • Postmarketing proarrhythmic cardiac safety assessments
  • Generalized cardiac safety
  • Medication errors, adherence, and concordance
  • Future directions in drug safety.